Navigation Links
Zeus: Dedicated to Advancing Biomaterial Technology with Enhanced Capabilities
Date:9/30/2009

ORANGEBURG, S.C., Sept. 30 /PRNewswire/ -- Zeus Inc., a global leader in material science and the manufacture of fluoropolymer tubing, announces its new state-of-the-art advanced materials laboratory dedicated exclusively to the extrusion, analysis, and characterization of Absorv(TM) Bioabsorbables. Zeus has also expanded its Absorv Bioabsorbables capabilities, including precision tubing ranging from outer diameters of 0.012in to 0.250in and tolerances as tight as +\- 0.0005in.

"Zeus has a history of being at the forefront of cutting-edge technology in polymer science and we are continuing that tradition in the field of absorbable materials," said Dr. Bruce Anneaux, Corporate Manager, Research & Development. "We have devoted an entirely new area to the development of bioabsorbables as these polymers will play a significant role in modern medical device design and next-generation therapies."

Zeus has dedicated 5,000 sq ft of laboratory space for the exploration and production of Absorv Bioabsorbables. The new facility is a controlled environment with an integral Class V clean room. The laboratory is staffed with a team of leading scientists, engineers, and technicians who are highly skilled and experienced in the field of biomaterial development. Laboratory staff also includes regulatory engineers and quality control personnel who are working to pursue new certification levels.

"Not only have we expanded our facilities and technical staff, but we have also designated a portion of our sales force to work solely with our partners in the field of bioabsorbables. Zeus has seen tremendous response to initial efforts within this field and it quickly became apparent we needed specific focus on this emerging product line," said Josh Ridley, Business Development Manager - Biomaterials. "Our goal is to help companies expand or improve their standard offerings through new processing and product forms."

Enhanced properties of Absorv Bioabsorbables include modulated degradation rates, varying strengths and stiffness, and FDA approval for medical devices. Zeus is currently processing these materials and providing multiple extrusion forms, such as shapes, special profiles, and multi-lumens. The product offering also includes precision tubing ranging from outer diameters of 0.012in to 0.250in and tolerances as tight as +\- 0.0005in; monofilament ranging from diameters of 0.003in to 0.060in; tape/ribbon; rod stock; and compounded pellet form. Zeus also provides absorbable polymers as cast films and non-woven microporous sheets.

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in material science and the production of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling and mechanical markets. For more information, visit http://www.zeusinc.com.

    Press Contact:

    Samantha Farlow
    Communications Coordinator
    (803) 268-9500
    publicrelations@zeusinc.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Zeus, Inc.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. UCSF and YouTube Launch Channel Dedicated to Educating the Public About Neurodegenerative Diseases
2. First Seed Sales of Dedicated Energy Crops Begin
3. Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience
4. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
5. American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health
6. International Society for Stem Cell Research Applauds Outcome of Proposal 2 Advancing Stem Cell Research
7. CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States
8. Nuclear fusion research key to advancing computer chips
9. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
10. National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications
11. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... ... of biologics. To acquire information on the desired increase and/or decrease in antibody-dependent ... industry for rapid N-glycosylation profiling of therapeutic antibodies. , To meet this ...
(Date:3/22/2017)... (PRWEB) , ... March 21, ... ... ( WMFTG ) has unveiled its innovative Quantum peristaltic pump with patented ... innovation, Quantum sets the new standard for high-pressure feed pumps in SU ...
(Date:3/22/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... Lebovits , Chief Executive Officer, will provide an update ... Associates 2 nd Annual Neuroscience Biopartnering and Investment ... the New York Academy of Sciences. ...
Breaking Biology Technology:
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
Breaking Biology News(10 mins):